AU2003227373A1 - Manufacturing method and formulation for bitter taste masked oral dosage form of clarithromycin - Google Patents

Manufacturing method and formulation for bitter taste masked oral dosage form of clarithromycin

Info

Publication number
AU2003227373A1
AU2003227373A1 AU2003227373A AU2003227373A AU2003227373A1 AU 2003227373 A1 AU2003227373 A1 AU 2003227373A1 AU 2003227373 A AU2003227373 A AU 2003227373A AU 2003227373 A AU2003227373 A AU 2003227373A AU 2003227373 A1 AU2003227373 A1 AU 2003227373A1
Authority
AU
Australia
Prior art keywords
clarithromycin
formulation
manufacturing
dosage form
oral dosage
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003227373A
Other languages
English (en)
Inventor
Dong-Hyun Cho
Young-Sig Gil
Seok-Cheon Hong
Chang-Hun Yu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Korea United Pharm Inc
Original Assignee
Korea United Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Korea United Pharm Inc filed Critical Korea United Pharm Inc
Publication of AU2003227373A1 publication Critical patent/AU2003227373A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2003227373A 2003-03-31 2003-04-22 Manufacturing method and formulation for bitter taste masked oral dosage form of clarithromycin Abandoned AU2003227373A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR10-2003-0019890A KR100508992B1 (ko) 2003-03-31 2003-03-31 쓴 맛을 개선한 클래리스로마이신 경구용 약제 조성물 및 그의 제조 방법
KR10-2003-0019890 2003-03-31
PCT/KR2003/000814 WO2004087112A1 (en) 2003-03-31 2003-04-22 Manufacturing method and formulation for bitter taste masked oral dosage form of clarithromycin

Publications (1)

Publication Number Publication Date
AU2003227373A1 true AU2003227373A1 (en) 2004-10-25

Family

ID=33128925

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003227373A Abandoned AU2003227373A1 (en) 2003-03-31 2003-04-22 Manufacturing method and formulation for bitter taste masked oral dosage form of clarithromycin

Country Status (3)

Country Link
KR (1) KR100508992B1 (ko)
AU (1) AU2003227373A1 (ko)
WO (1) WO2004087112A1 (ko)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005082331A2 (en) * 2004-02-26 2005-09-09 Ranbaxy Laboratories Limited Extended release tablets of clarithromycin
KR100676075B1 (ko) * 2005-02-17 2007-02-01 한국유나이티드제약 주식회사 경구투여용 클래리스로마이신 함유 펠렛 제제
KR101436516B1 (ko) * 2007-07-23 2014-09-02 주식회사태평양제약 코팅된 펠렛을 함유하는 현탁정 및 이의 제조방법
CN101502492B (zh) * 2009-03-13 2013-11-27 上海微丸医药开发有限公司 一种克拉霉素去苦味颗粒的制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3265680B2 (ja) * 1992-03-12 2002-03-11 大正製薬株式会社 経口製剤用組成物
US5466712A (en) * 1994-11-04 1995-11-14 American Home Products Corporation Substituted n-aryl-1,2-diaminocyclobutene-3,4-diones
EP0826376B1 (en) * 1995-05-02 2007-01-24 Taisho Pharmaceutical Co. Ltd Composition for oral administration
AUPO637197A0 (en) * 1997-04-23 1997-05-15 F.H. Faulding & Co. Limited Taste-masked pharmaceutical compositions
DE19840256A1 (de) * 1998-09-03 2000-03-09 Basf Ag Verfahren zur Herstellung von beschichteten festen Dosierungsformen

Also Published As

Publication number Publication date
KR100508992B1 (ko) 2005-08-17
WO2004087112A1 (en) 2004-10-14
KR20040085256A (ko) 2004-10-08

Similar Documents

Publication Publication Date Title
AU2003259417A1 (en) Taste masked dosage forms and processes for their preparation
EP1365747A4 (en) PHARMACEUTICAL PRESENTATION OF ORAL PEPTIDE ADMINISTERED AND METHOD OF PRODUCTION
HUP0303800A3 (en) Pharmaceuticals and dosage forms of epothilones for oral administration
GB0219516D0 (en) Fast dissolving and taste masked oral dosage form comprising sildenafil
HRP20050867A2 (en) Pharmaceutical compositions having reduced bitter taste
HK1067558A1 (en) Pharmaceutical formulation having a masked taste and method for the production thereof
AU2003298583A1 (en) Chewing gum formulation and method of making the same
AU2002352533A1 (en) Methods and compositions for treatment of gastric diseases
HK1066459A1 (en) Pharmaceutical dosage form and method of making
AU2003221699A1 (en) Pharmaceutical preparation for taste masking
IL175657A0 (en) Derivatives of dihydronepetalactone and method for preparation
AU2003276572A1 (en) Pharmaceutical dosage forms of biguanide-sulfonylurea combinations
IL169428A (en) Acylaminothiazole derivatives, preparation method thereof, pharmaceutical compositions comprising them and use of same in the manufacture of beta-amyloid peptide production inhibitors
AU2002329311A1 (en) Pharmaceutical formulation having a masked taste and method for the production thereof
AU2003292509A1 (en) Taste masked pharmaceutical compositions comprising bitter drug and ph sensitive polymer
AU2003249478A1 (en) Taste masked sumatriptan tablets and processes for their preparation
AU2003237574A1 (en) Confectionery product and method of preparation
AU2003227373A1 (en) Manufacturing method and formulation for bitter taste masked oral dosage form of clarithromycin
AU2002246950A1 (en) Hydrocapsules and method of preparation
AU2002242223A1 (en) Flavored coffee compositions and method of making
AU2003256157A1 (en) Oral dosage forms of water insoluble drugs and methods of making the same
AU2003227789A1 (en) Inhalator and method of manufacturing same
ZA200408569B (en) Taste masked compositions of erythromycin A and derivatives thereof.
AU2003251303A1 (en) Pharmaceutical products and methods of manufacture
EP1581258A4 (en) PHARMACEUTICAL FORMULATION AND MANUFACTURING METHOD THEREFOR

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase